特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
235292

白斑:世界の治験動向

Vitiligo Global Clinical Trials Review, H2, 2018

出版日: | 発行: GlobalData | ページ情報: 英文 110 Pages | 納期: 即納可能 即納可能とは

価格
こちらの商品の販売は終了いたしました
白斑:世界の治験動向
出版日: 2018年09月28日
発行: GlobalData
ページ情報: 英文 110 Pages
納期: 即納可能 即納可能とは

当商品の販売は、2020年09月04日を持ちまして終了しました。

  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、白斑の治験 (臨床試験) に関する最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 白斑
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:皮膚科疾患治療薬の治験における白斑の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:皮膚科疾患治療薬の治験における白斑の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

白斑の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Clinuvel Pharmaceuticals Limited
    • Novartis AG
    • アステラス製薬
    • Nestle S.A.
    • Laboratoires Genevrier S.A.
    • Bristol-Myers Squibb Company
    • Avemedica, s.r.o.
    • Applied Biology, Inc.
    • Ache Laboratorios Farmaceuticos S/A
    • A.R.I.V. Onlus
  • 代表的な研究機関・病院の治験の概要
    • First Hospital of China Medical University
    • Henry Ford Health System
    • University of British Columbia
    • Academic Medical Center
    • Centre Hospitalier Universitaire de Nice
    • Ghent University Hospital
    • Institute for Post Graduate Teaching & Research in Ayurveda
    • Isfahan University of Medical Sciences
    • Kermanshah University of Medical Sciences
    • King Saud University

5つの代表的な治験のプロファイル

付録

図表

List of Tables

  • Vitiligo Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Vitiligo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Vitiligo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Vitiligo Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Vitiligo Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
  • Vitiligo Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Vitiligo Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
  • Vitiligo Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
  • Proportion of Vitiligo to Dermatology Clinical Trials, G7 Countries (%), 2018* 16
  • Vitiligo Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Vitiligo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Vitiligo to Dermatology Clinical Trials, E7 Countries (%), 2018* 19
  • Vitiligo Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
  • Vitiligo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
  • Vitiligo Therapeutics, Global, Clinical Trials by Phase, 2018* 22
  • Vitiligo Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
  • Vitiligo Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
  • Vitiligo Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
  • Vitiligo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
  • Vitiligo Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 28
  • Vitiligo Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
  • Vitiligo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
  • Vitiligo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33

List of Figures

  • Vitiligo Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Vitiligo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Vitiligo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Vitiligo Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Vitiligo Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
  • Vitiligo Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
  • Vitiligo Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
  • Proportion of Vitiligo to Dermatology Clinical Trials, G7 Countries (%), 2018* 16
  • Vitiligo Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Vitiligo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Vitiligo to Dermatology Clinical Trials, E7 Countries (%), 2018* 19
  • Vitiligo Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
  • Vitiligo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
  • Vitiligo Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
  • Vitiligo Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
  • Vitiligo Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
  • Vitiligo Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
  • Vitiligo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
  • Vitiligo Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 28
  • Vitiligo Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
  • Vitiligo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
  • Vitiligo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33
  • GlobalData Methodology 109
目次
Product Code: GDHC5308CTIDB

GlobalData's clinical trial report, "Vitiligo Global Clinical Trials Review, H2, 2018" provides an overview of Vitiligo clinical trials scenario. This report provides top line data relating to the clinical trials on Vitiligo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Vitiligo to Dermatology Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Vitiligo to Dermatology Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Vitiligo Therapeutics Clinical Trials 31
  • Prominent Drugs 33
  • Clinical Trial Profile Snapshots 34

Appendix 108

  • Abbreviations 108
  • Definitions 108
  • Research Methodology 109
  • Secondary Research 109
  • About GlobalData 109
  • Contact Us 110
  • Source 110
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.